Business contact info for : igdmabtech.com

IgD Mab Technology (IMT) – IMT is a privately held Australian biotechnology startup company that focuses on the clinical & commercial development of therapeutic anti-IgD monoclonal antibody (mAb) into a new innovative and advanced disease-modifying mAb treatment for human autoimmune diseases allergic skin inflammations and B-CLL.

https://igdmabtech.com Direct contact link IMT is a privately-held Australian biotechnology startup company that was formed in Aug-2018.  IMT focuses on the clinical & commercial development of therapeutic anti-IgD monoclonal antibody (mAb) Tuessayzumab into a new life saving and advanced disease-modifying mAb treatment for human autoimmune diseases allergic skin inflammations and chronic B-cell lymphocytic leukemia (B-CLL).  IMT was founded in… ceo***@igdmabtech.com igd.mabtech***********@gmail.com

This company may appear in the following contact lists::

IMT	Privately
Privately Held	Privately Held Australian
Held Australian Biotechnology	Australian Biotechnology Startup
Biotechnology Startup Company	Startup Company
Company Focuses	Focuses On
Focuses On	On Clinical
Clinical	Clinical Commercial
Commercial Development	Commercial Development
Development Therapeutic	Therapeutic Anti
Therapeutic Anti IgD	Anti IgD Monoclonal
IgD Monoclonal Antibody	Into New
New Innovative	New Innovative
Innovative Advanced	Advanced Disease
Advanced Disease modifying	Disease modifying MAb

For a limited time, sign up to our Starter Plan for $4.99 a month to unhide all information about the company.